Auto saved by Logseq

pages/STOP2030___Annual Meeting___2024___Notas.md

@@ -2,4 +2,4 @@
 - [[Ale]]: brief intro to all the teams. Listen about the purpose of our presence is. How many goals have already been achieved.
 - Help improving the delivery of tools of tools and strategies for controlling STH but also integration with other diseases.
 - [[Charles Mwandawiro]]: WHO Roadmap 2030. Why 2030? Efforts to control STH. We talk about elimination in 2030. It used to look quite far, but its only 6 years away. STH are ntds.
-- NTD Kenya: We're at the boundary.  We have a problem of NTDs. It can not be understated. Our colleages from the School of Health launched interventions to combat schisto and STH in 2012. As Dr. Mwandawiro indicated, nosequé. We're still seeing peaks of infection.
+- NTD Kenya: We're at the boundary.  We have a problem of NTDs. It can not be understated. Our colleages from the School of Health launched interventions to combat schisto and STH in 2012. As Dr. Mwandawiro indicated, nosequé. We're still seeing peaks of infection. Albendazole and mebendazole. We're not using a combination. We realized that we're not able to achieve our goal through MDA alone. In the Breaking Transmission Strategy(BTS) also calls for complimentary interventions. How we can augment the